DK174687B1 - Farmaceutisk sammensætning med analgetisk aktivitet til oral anvendelse og farmaceutisk doseringsform - Google Patents

Farmaceutisk sammensætning med analgetisk aktivitet til oral anvendelse og farmaceutisk doseringsform Download PDF

Info

Publication number
DK174687B1
DK174687B1 DK199400725A DK72594A DK174687B1 DK 174687 B1 DK174687 B1 DK 174687B1 DK 199400725 A DK199400725 A DK 199400725A DK 72594 A DK72594 A DK 72594A DK 174687 B1 DK174687 B1 DK 174687B1
Authority
DK
Denmark
Prior art keywords
ibuprofen
arginine
composition
pharmaceutical
dosage form
Prior art date
Application number
DK199400725A
Other languages
Danish (da)
English (en)
Other versions
DK72594A (da
Inventor
Daniele Bonadeo
Federico Stroppolo
Annibale Gazzaniga
Gian Franco Fornasini
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of DK72594A publication Critical patent/DK72594A/da
Application granted granted Critical
Publication of DK174687B1 publication Critical patent/DK174687B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
DK199400725A 1993-06-21 1994-06-20 Farmaceutisk sammensætning med analgetisk aktivitet til oral anvendelse og farmaceutisk doseringsform DK174687B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001325A IT1264856B1 (it) 1993-06-21 1993-06-21 Composizione farmaceutica ad attivita' analgesica
ITMI931325 1993-06-21

Publications (2)

Publication Number Publication Date
DK72594A DK72594A (da) 1994-12-22
DK174687B1 true DK174687B1 (da) 2003-09-15

Family

ID=11366436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199400725A DK174687B1 (da) 1993-06-21 1994-06-20 Farmaceutisk sammensætning med analgetisk aktivitet til oral anvendelse og farmaceutisk doseringsform

Country Status (15)

Country Link
US (2) US5500226A (no)
JP (1) JPH07101855A (no)
BE (1) BE1007194A3 (no)
CA (1) CA2125643C (no)
CH (1) CH687850A5 (no)
DE (1) DE4420856A1 (no)
DK (1) DK174687B1 (no)
ES (1) ES2099021B1 (no)
FR (1) FR2706892B1 (no)
GB (1) GB2279250B (no)
HU (1) HU211669A9 (no)
IT (1) IT1264856B1 (no)
NL (1) NL193820C (no)
NO (1) NO310443B1 (no)
SE (1) SE9402157L (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
US5707967A (en) * 1995-10-27 1998-01-13 Vanmoor; Arthur Pain relief compositions
US6177467B1 (en) 1996-09-26 2001-01-23 Oklahoma Medical Research Foundation Use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester and its derivatives in disease regression
WO1999051252A1 (en) * 1998-04-03 1999-10-14 The Daily Wellness Company Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
EP1379226A2 (en) * 2001-04-10 2004-01-14 Zagros Pharma Inc. Animal model for evaluating analgesics
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
KR100678837B1 (ko) * 2005-01-03 2007-02-05 한미약품 주식회사 활성 성분으로 덱시부프로펜을 함유하는 시럽제 조성물 및그의 제조 방법
KR100730393B1 (ko) 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
MX2010004974A (es) * 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
PT95564B (pt) * 1989-10-17 1997-11-28 Merck & Co Inc Processo para a preparacao de (+)-ibuprofen-d-aminoacido uteis como analgesicos intensificados de ataque acelerado
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica

Also Published As

Publication number Publication date
CA2125643C (en) 2007-09-04
NO942343D0 (no) 1994-06-20
JPH07101855A (ja) 1995-04-18
US5645857A (en) 1997-07-08
FR2706892A1 (no) 1994-12-30
ES2099021A1 (es) 1997-05-01
ES2099021B1 (es) 1998-01-16
NO310443B1 (no) 2001-07-09
GB2279250B (en) 1998-02-25
DK72594A (da) 1994-12-22
ITMI931325A0 (it) 1993-06-21
NL9401005A (nl) 1995-01-16
GB9410898D0 (en) 1994-07-20
CA2125643A1 (en) 1994-12-22
BE1007194A3 (fr) 1995-04-18
NL193820B (nl) 2000-08-01
NL193820C (nl) 2000-12-04
DE4420856A1 (de) 1994-12-22
GB2279250A (en) 1995-01-04
FR2706892B1 (no) 1995-10-20
HU211669A9 (en) 1995-12-28
NO942343L (no) 1994-12-22
SE9402157L (sv) 1994-12-22
US5500226A (en) 1996-03-19
CH687850A5 (it) 1997-03-14
IT1264856B1 (it) 1996-10-17
ITMI931325A1 (it) 1994-12-21
SE9402157D0 (sv) 1994-06-20

Similar Documents

Publication Publication Date Title
DK174687B1 (da) Farmaceutisk sammensætning med analgetisk aktivitet til oral anvendelse og farmaceutisk doseringsform
NL193307C (nl) Bruispreparaat met analgetische werkzaamheid.
Mutalik et al. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac
US5510385A (en) Pharmaceutical compositions containing the salts of S(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids
EP1904067B1 (en) Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition
IE871745L (en) Analgesic compositions
NO326639B1 (no) Farmasoytiske sammensetninger inneholdende et brusende syre-base par
US11013736B2 (en) Oral solid preparation and use thereof
WO2011053504A1 (en) Solid pharmaceutical compositions containing an integrase inhibitor
KR20190040184A (ko) 2성분 조성물
US20220409701A1 (en) Process for producing a tablet comprising glp-1 peptides
WO2011136751A2 (en) Water soluble pharmaceutical composition
US11013707B2 (en) Administration of oral methyldopa
KR101083873B1 (ko) 애엽에 함유되어 있는 혈액응고 억제작용을 갖는 성분의 제거방법
KR20030076051A (ko) 실데나필 젖산염의 속효제형
NO333977B1 (no) Oromukosalpreparat og fremgangsmåte for fremstilling derav.
KR100908193B1 (ko) 애엽추출물의 가용화 방법
RU2276982C2 (ru) Средство, обладающее противовоспалительным, анальгетическим, жаропонижающим действием в форме таблетки
KR101584919B1 (ko) 암로디핀 경구 붕해형 정제용 조성물 및 이의 제조방법